
Top stories of the week on Specialty Pharmacy Times from May 11 to May 15.

Top stories of the week on Specialty Pharmacy Times from May 11 to May 15.

Drugs that activate nervous system stem cells may cause formation of new myelin.

Infant antibiotic use may be linked with disease later in life.

Link found between new onset obstructive sleep apnea and habitual sleepiness.

Black men more likely to be diagnosed with breast cancer at a younger age than white men.

Study may add to the ability to predict RA outcomes.

Collaboration creates industry-leading alliance providing pharmacy consulting, talent acquisition, legal and accounting services to the rapidly growing specialty pharmacy industry.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the impact of the Affordable Care Act on specialty pharmacy.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the significance of the annual Armada Specialty Pharmacy Summit.

Excess medical expenses, employment disability, and a drop in production at work common in cancer survivors.

Promising results from generic formulation of drug used post-transplant to reduce the risk of organ rejection.

Study warns that drug reviewers don't look at long term survival of patients.

Investigational 3-drug combination cleared the virus in 93% of treatment-naïve patients.

Particles protected antigen from premature destruction and prompted the immune system to attack cancer cells.

The FDA is actively investigating vulnerabilities identified in Hospira's LifeCare PCA3 and PCA5 infusion pump systems.

Direct-acting-antiviral drugs daclatasvir, asunaprevir, and beclabuvir showed high rates of sustained virologic response after 12 weeks.

Age and weight found to play a role in side effects.

Regular trips to the emergency department could be a red flag for deadly prescription drug overdose.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses changes in store for the care of cancer patients over the next decade.

Mass spectrometry reveals all proteins that repair damaged cancer DNA.

Targeting gene mutations causes stress that damages cancer cell DNA.

Many consultant pharmacists are taking on new roles and responsibilities in the shifting long-term care landscape, allowing them to perform a number of enhanced services.

Treating immune-suppressing cells allows for destruction of tumors.

Study finds chronic hepatitis C has a limited impact on mortality unless the patient has other severe comorbidities.

Washington State Governor Jay Inslee signed into law on May 11, 2015, a bill that makes Washington the first state in the country to require that pharmacists are included in health insurance provider networks.

Even healthy adults taking statins are 87% more likely to develop diabetes.

Liver damage is the bane of HIV-infected patients' existence.

Veterans Affairs covers few compounded medications through pharmacies and via mail order.

A look back at the top stories on Specialty Pharmacy Times from May 4 to May 8.

Implant delivers sustained release of ARV drugs up to 40 days with no adverse side effects.